1. Home
  2. SHMD vs IVVD Comparison

SHMD vs IVVD Comparison

Compare SHMD & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCHMID Group N.V. Class A Ordinary Shares

SHMD

SCHMID Group N.V. Class A Ordinary Shares

SELL

Current Price

$2.98

Market Cap

198.2M

Sector

N/A

ML Signal

SELL

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$0.68

Market Cap

212.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHMD
IVVD
Founded
1864
2020
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
212.6M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
SHMD
IVVD
Price
$2.98
$0.68
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
1.3M
★ 5.6M
Earning Date
11-25-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 79.02
EPS
★ N/A
N/A
Revenue
N/A
★ $53,426,000.00
Revenue This Year
$49.82
$12.40
Revenue Next Year
$36.39
$44.85
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 110.47
52 Week Low
$2.93
$0.53
52 Week High
$10.65
$3.07

Technical Indicators

Market Signals
Indicator
SHMD
IVVD
Relative Strength Index (RSI) 33.45 40.08
Support Level N/A $0.53
Resistance Level $3.65 $1.02
Average True Range (ATR) 0.38 0.06
MACD -0.13 -0.02
Stochastic Oscillator 3.23 16.35

Price Performance

Historical Comparison
SHMD
IVVD

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

About IVVD Invivyd Inc.

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

Share on Social Networks: